VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HAO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HAOHaoxi Health Technology Limited
$1.02$5M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHAOQuarterly Financials

Haoxi Health Technology Limited (HAO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Haoxi Health Technology Limited (HAO) quarterly income statement — complete revenue, gross profit & net income history

HAO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ2'26Q4'25Q2'25Q4'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21
Sales/Revenue33.83M8.85M23.95M25.02M23.5M19.07M9.16M8.08M8.08M6.42M
Revenue Growth %41.22%-64.63%1.92%31.21%156.51%136.02%13.42%25.76%--
Cost of Goods Sold32.23M8.4M23.47M23.47M22.3M17.73M8.43M7.75M7.75M6.12M
COGS % of Revenue95.28%94.94%97.99%93.81%94.89%93.01%92.03%95.98%95.98%95.29%
Gross Profit1.6M447.36K480.39K1.55M1.2M1.33M730.23K324.36K324.36K302.79K
Gross Margin %4.72%5.06%2.01%6.19%5.11%6.99%7.97%4.02%4.02%4.71%
Gross Profit Growth %232.32%-71.11%-60.01%16.28%64.52%310.6%125.13%7.12%--
Operating Expenses7.28M2.32M607.74K650.11K383.02K614.25K237.63K189.98K189.98K137.51K
OpEx % of Revenue21.51%26.22%2.54%2.6%1.63%3.22%2.59%2.35%2.35%2.14%
Selling, General & Admin7.21M2.31M540.19K600.97K352.17K594.5K213.6K138.72K138.72K106.19K
SG&A % of Revenue21.33%26.08%2.25%2.4%1.5%3.12%2.33%1.72%1.72%1.65%
Research & Development61.17K11.99K67.56K49.14K30.84K34.32K23.84K51.26K51.26K31.32K
R&D % of Revenue0.18%0.14%0.28%0.2%0.13%0.18%0.26%0.63%0.63%0.49%
Other Operating Expenses00000003943940
Operating Income-5.68M-1.87M-127.35K1.55M818.37K703.02K492.79K134.38K134.38K165.28K
Operating Margin %-16.79%-21.16%-0.53%6.19%3.48%3.69%5.38%1.66%1.66%2.57%
Operating Income Growth %-4359.4%-220.92%-115.56%120.28%66.07%423.14%266.7%-18.69%--
EBITDA-5.42M-1.86M-117.82K1.55M829.96K709.71K494.5K135.49K135.49K165.48K
EBITDA Margin %-16.03%-21.07%-0.49%6.19%3.53%3.72%5.4%1.68%1.68%2.58%
EBITDA Growth %-4503.26%-220.5%-114.2%118.06%67.84%423.8%264.97%-18.12%--
D&A (Non-Cash Add-back)255.54K7.75K9.53K-1.02K11.58K6.69K1.71K1.11K1.11K206
EBIT-5.68M4.19M2.08K959.42K818.37K703.02K492.79K134.78K134.78K165.28K
Net Interest Income38.64K183.7K133.65K51.7K-16.79K13.23K6.55K-4.98K-4.98K-2.63K
Interest Income38.64K229.66K133.65K76.1K013.23K6.55K000
Interest Expense045.96K024.4K16.79K24.4K16.79K4.98K4.98K2.63K
Other Income/Expense-861.36K6.02M129.43K36.15K-18.14K1.34K-6.74K-4.59K-4.59K-2.63K
Pretax Income-6.54M4.15M2.08K935.02K800.23K704.36K486.05K129.8K129.8K162.64K
Pretax Margin %-19.33%46.84%0.01%3.74%3.4%3.69%5.3%1.61%1.61%2.53%
Income Tax340.7K36.13K234.61K403.55K40.03K181.65K39K7.5K7.5K10.61K
Effective Tax Rate %-5.21%0.87%11295.62%43.16%5%25.79%8.02%5.78%5.78%6.52%
Net Income-6.88M4.11M-232.53K529.8K760.2K522.71K447.05K122.29K122.29K152.03K
Net Margin %-20.34%46.44%-0.97%2.12%3.23%2.74%4.88%1.51%1.51%2.37%
Net Income Growth %-2859.22%675.61%-130.59%1.36%70.05%327.42%265.55%-19.56%--
Net Income (Continuing)-6.88M4.11M-232.53K531.47K760.2K522.71K447.05K122.29K122.29K152.03K
Discontinued Operations0000000000
Minority Interest0000000000
EPS (Diluted)-1.531.42-0.010.040.060.040.040.010.010.00
EPS Growth %-11669.23%3280.95%-120.31%-2.33%45.45%230.77%340%---
EPS (Basic)-1.531.42-0.010.040.060.040.040.010.010.00
Diluted Shares Outstanding4.49M2.9M18.15M12.69M11.79M11.94M10.15M10M10M318.8M
Basic Shares Outstanding4.49M2.9M18.15M12.84M11.79M12.17M10.15M10M11.09M318.8M
Dividend Payout Ratio----------